Helidac Therapy Pack
RxNorm 758020

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 758020 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Helidac Therapy Pack.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Helidac Therapy Pack
AUI:6373108
View
SY
Helidac Therapy Pack
AUI:2771452
View
BPCK
{112 (bismuth subsalicylate 262 mg Chewable Tablet) / 56 (metronidazole 250 mg Oral Tablet) / 56 (tetracycline hydrochloride 500 mg Oral Capsule) } Pack [Helidac Therapy]
AUI:12869297
View
TMSY
{112 (bismuth subsalicylate 262 mg Chewable Tablet) / 56 (metroNIDAZOLE 250 mg Oral Tablet) / 56 (tetracycline hydrochloride 500 mg Oral Capsule) } Pack [Helidac Therapy]
AUI:12869538
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
Helidac Therapy Pack
(Atom ID: 6373108)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Helidac Therapy Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
758020
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6373108
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
758020
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Helidac Therapy Pack
(Atom ID: 2771452)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Helidac Therapy Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
758020
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
2771452
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
758020
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
BPCKPrescribable

Brand Name Pack (BPCK):
{112 (bismuth subsalicylate 262 mg Chewable Tablet) / 56 (metronidazole 250 mg Oral Tablet) / 56 (tetracycline hydrochloride 500 mg Oral Capsule) } Pack [Helidac Therapy]
(Atom ID: 12869297)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{112 (bismuth subsalicylate 262 MG Chewable Tablet) / 56 (metronidazole 250 MG Oral Tablet) / 56 (tetracycline hydrochloride 500 MG Oral Capsule) } Pack [Helidac Therapy]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
758020
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12869297
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
758020
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans
TMSYPrescribable

Tall Man Lettering Synonym (TMSY):
{112 (bismuth subsalicylate 262 mg Chewable Tablet) / 56 (metroNIDAZOLE 250 mg Oral Tablet) / 56 (tetracycline hydrochloride 500 mg Oral Capsule) } Pack [Helidac Therapy]
(Atom ID: 12869538)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{112 (bismuth subsalicylate 262 MG Chewable Tablet) / 56 (metroNIDAZOLE 250 MG Oral Tablet) / 56 (tetracycline hydrochloride 500 MG Oral Capsule) } Pack [Helidac Therapy]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
758020
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12869538
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
TMSY
Tall Man Lettering Synonym (Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.)
Source Code
758020
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.